Discover 1,933 paid clinical trials in Richardson, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,933
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
for
Colorectal Cancer
Location: Grapevine TX, Fort Worth TX, Austin TX, Houston TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07023289
Phase 2, Recruiting
Featured
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
Location: Red Oak TX, Jackson TN, Anniston AL, Orland Park IL,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07607964
Phase 1, Recruiting
Featured
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
for
Chronic Migraine
Location: Waxahachie TX, Austin TX, Houston TX, Little Rock AR,
Sponsor: AbbVie
Sex: All
Age: 12 - 17
Code: NCT06810505
Phase 3, Recruiting
Featured
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
for
Metastatic Breast Cancer
Location: Fort Worth TX, El Paso TX, The Woodlands TX, Gilbert AZ,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05894239
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
for
Breast Cancer
Location: Fort Worth TX, Spring TX, Germantown TN, Kansas City MO,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06790693
Phase 3, Recruiting
Featured
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
for
HER2-positive Breast Cancer
Location: Fort Worth TX, Austin TX, Germantown TN, Huntsville AL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07413939
Phase 2, Phase 3, Recruiting
Featured
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Fort Worth TX, Tyler TX, Shreveport LA, Austin TX,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06890338
Phase 2, Recruiting
Featured
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
for
Neovascular Age-related Macular Degeneration
Location: Burleson TX, Round Rock TX, Abilene TX, Austin TX,
Sponsor: AbbVie
Sex: All
Age: 50+
Code: NCT07007065
Phase 3, Recruiting
Active & Responsive
Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
for
Schizophrenia
Location: Richardson TX, Little Rock AR
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18 - 60
Code: NCT07680946
Phase 2, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
for
Major Depressive Disorder (MDD)
Location: Richardson TX, Plano TX, Witchita Falls TX, Houston TX,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT06830044
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine